In confirmation of this, retroviral transduction of murine bone marrow with the BCR-ABL1 fusion led to a CML-like myeloproliferative disorder in mice [17], proving the oncogenic capacity of this fusion protein and its central role in CML. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.